Anna Durbin
Professor, International Health and Director of the Center for Immunization Research
My work focuses on the development and evaluation of vaccines for emerging infectious diseases such as dengue and Zika. I have collaborated with vaccine manufacturers in India to manufacture and evaluate a live attenuated tetravalent dengue vaccine in India. The U.S. National Institutes of Health as licensed this technology to several vaccine manufacturers in India with the goal of in-country production and delivery of this vaccine to benefit those at risk in India.